Stock Events

Stock Events

Can-Fite Biopharma (CANF) Q3 2026 Earnings

27AugConfirmed

Q2 2025

Q3 2025

Q1 2026

-0

-0

-0

0

Details

Expected EPS

-0.003996

Actual EPS

N/A

Surprise EPS

0

Surprise Percent

+100%

Description

Can-Fite Biopharma (CANF) will report earnings of for Q3 2026 on August 27, 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.